Cross Country Healthcare (CCRN) Reports In-Line Q1 EPS, Offers Q2 Guidance
Cross Country Healthcare (NASDAQ: CCRN) reported Q1 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $186 million versus the consensus estimate of $187 million.
Cross Country Healthcare sees Q2 EPS of $0.05-$0.07, versus the consensus of $0.06. Cross Country Healthcare sees FY2015 revenue of $188-192 million, versus the consensus of $193.3 million.
For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.
